[Prognostic value of fetal thymidine kinase measurements in breast cancer].
Estimation of fetal Thymidine Kinase activity in primary tumors could be a useful parameter in the assessment of early relapses in patients with breast cancer. In a group of 39 women followed up for 42 months, the percentage of early relapses and their frequency was significantly higher in patients whose tumors had a high level of enzyme activity than in others.
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000201:enzymology*; D005260:Female; D005333:Fetus / Q000201:enzymology; D006801:Humans; D007527:Isoenzymes / Q000032:analysis*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D011379:Prognosis; D013937:Thymidine Kinase / Q000032:analysis*
D014408:Biomarkers, Tumor; D007527:Isoenzymes; D013937:Thymidine Kinase
Intérêt pronostique du dosage de l'activité de la thymidine kinase foetale dans les cancers du sein.